SMSPHARMA.BOSMSPHARMA.BOBSE
Loading
Operating cash flow minus capital expenditures
Percentile
P14
Within normal range
vs 3Y Ago
-4.5x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-588.57M | -2791.8% |
| 2024 | $-20.35M | +72.8% |
| 2023 | $-74.71M | -157.5% |
| 2022 | $129.86M | +121.2% |
| 2021 | $-612.96M | -1928.2% |
| 2020 | $-30.22M | -120.3% |
| 2019 | $149.19M | -35.9% |
| 2018 | $232.62M | -63.3% |
| 2017 | $633.91M | +330.0% |
| 2016 | $-275.67M | - |